The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis
Author(s) -
Fabian Kong,
Sepehr N. Tabrizi,
Christopher K. Fairley,
Lenka A. Vodstrcil,
Wilhelmina M. Huston,
Marcus Y. Chen,
Catriona S. Bradshaw,
Jane S. Hocking
Publication year - 2015
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku574
Subject(s) - azithromycin , doxycycline , medicine , chlamydia , chlamydia trachomatis , meta analysis , randomized controlled trial , observational study , clinical trial , antibiotics , gynecology , immunology , microbiology and biotechnology , biology
There are increasing concerns about treatment failure following treatment for rectal chlamydia with 1 g of azithromycin. A systematic review and meta-analysis was conducted to investigate the efficacy of 1 g of azithromycin as a single dose or 100 mg of doxycycline twice daily for 7 days for the treatment of rectal chlamydia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom